shenxiu2 发表于 2010-11-21 10:34:07

ANZCA EXAM Q 1996A06--neuroanesthesia

1996A06:   A previously well 38 yo man presents for urgent clipping of a middle cerebral artery aneurysm.He has photophobia, and a blood pressure of 150/90

Outline how you would manage post-operative vasospasm in this patient

General Measures

•      Ensure adequate patent airway and avoid hypoxaemia
•      Monitor in intensive care unit.
o      CVP
o      invasive arterial pressure recording
o      Regular monitoring of neurological state is essential.

Specific Measures to increase perfusion:

•      Triple H therapy – mainstay of mx since 1970s – prospectively shown to reduce morbidity and mortality from vasospasm ~20% (1980s) to 5-10% although RCT data not available.

o      Hypervolaemia:
      Volume load with colloid (eg 5% Albumin or Gelofusine)
      NS may be used (glucose and low sodium containing solutions are avoided)
      Problems with pulmonary oedema, worsening cerebraloedema, myocardial ischaemia, haemorrhagic infaction
      Only one prospective study supports use
      Outcomes with hypervolaemia vs. normovolaemia compared in 1999 with RCT – no difference in global cerebral blood flow
      Many patients with SAH present hypovolaemic – it is felt that this is more important to prevent
      CVP aim usually 8-10 cmH2O

o      Haemodilution
      Eg Hb < = 11 g/dL

o      Hypertension
      Prior to aneurysm clipping aim for SBP < 110 mmHg or within 20% of baseline
      Post – clipping: usually 20-30% above baseline – eg 150-170 mHg
      may require the use of inotropic support e.g. low dose adr, NA

•      calcium channel blockade - nimodipine is the drug of choice ( 60mg 4/24 for 21 days). Fausidil HCl is an alternative.
o      shown to reduce the incidence and severity of vasospasm.
o      mechanism remains unclear; possible vasodilation by calcium channel block, or free radical scavenging.
o      Should be given either as IV infusion with accompanying flushing solution through a central line, or can be given orally three times per day.
o      Should be commenced early in the management.
o      Nicardipine has failed to show benefit
页: [1]
查看完整版本: ANZCA EXAM Q 1996A06--neuroanesthesia


论坛郑重声明 本站供网上自由讨论使用,所有个人言论并不代表本站立场,所发布资源均来源于网络,假若內容有涉及侵权,请联络我们。我们将立刻删除侵权资源,并向版权所有者致以诚挚的歉意!